AbbVie Inc: director Susan E Quaggin received 59 shares

What happened Susan E Quaggin, a director, received an award/acquisition of 59 stock equivalent units at $261.59 per share, for a total value of $15,434. The filing classifies the units as derivative stock equivalent units.

Key details

• Transaction date and price: Sep 30, 2026 — 59 shares at $261.59 per share.
• Total value reported: $15,434.
• Shares owned after the transaction: not specified in the provided filing data.
• Footnotes from the filing:
  • F1: Director fees credited to an unfunded book account in the director's name are distributed over a period equal to the director's years of board service, generally commencing at the later of age 65 or upon retirement from the board; the stock equivalent units earn the same return as if the fees were invested in AbbVie stock.
  • F2: Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.
• Filing date: Oct 02, 2026 (transaction reported for Sep 30, 2026).

Why it may matter This was a grant/award of derivative stock equivalent units, not an open-market purchase or sale. The filing does not show why the insider traded or why the company acted.